MedTrace Logo

Health Impact Study of Aquatabs in Tamale, Ghana

NCT00252928 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2007-10-30

No results posted yet for this study

Summary

The purpose of this study to determine whether Aquatabs, a water treatment tablet, reduces diarrheal diseases in a peri-urban population of Tamale, Ghana.

Conditions

Interventions

OTHER

Sodium dichloroisocyanurate (NaDCC) tablets

Intervention arm receives NaDCC tablets to use for to disinfect their household water for use for 20L of water. Ideally, disinfection occurs every day.

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Medentech

    collaborator INDUSTRY

  • Emory University Center for Global Safe Water

    collaborator OTHER

  • NewEnergy

    collaborator UNKNOWN

  • University for Development Studies, Tamale, Ghana

    collaborator OTHER

  • Centers for Disease Control and Prevention

    lead FED

Principal Investigators

  • Seema Jain, MD · Centers for Disease Control and Prevention

  • Robert Quick, MD · Centers for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Completion
2006-11-30

Countries

  • United States
  • Ghana

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00252928 on ClinicalTrials.gov